SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-074421
Filing Date
2011-08-08
Accepted
2011-08-08 16:08:53
Documents
9
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c19439e10vq.htm 10-Q 295107
2 EXHIBIT 31.1 c19439exv31w1.htm EX-31.1 9227
3 EXHIBIT 31.2 c19439exv31w2.htm EX-31.2 9244
4 EXHIBIT 32.1 c19439exv32w1.htm EX-32.1 4478
  Complete submission text file 0000950123-11-074421.txt   1640570

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT anx-20110630.xml EX-101.INS 158506
6 EX-101 SCHEMA DOCUMENT anx-20110630.xsd EX-101.SCH 14173
7 EX-101 CALCULATION LINKBASE DOCUMENT anx-20110630_cal.xml EX-101.CAL 43698
8 EX-101 LABELS LINKBASE DOCUMENT anx-20110630_lab.xml EX-101.LAB 130860
9 EX-101 PRESENTATION LINKBASE DOCUMENT anx-20110630_pre.xml EX-101.PRE 78390
Mailing Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130 8585520866
ADVENTRX PHARMACEUTICALS INC (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 111017315
SIC: 2834 Pharmaceutical Preparations